Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05953779Not ApplicableUnknown

Personalized Need-focused Single Session Intervention

Role: collaborator

NCT02272959Not ApplicableUnknown

Attention Bias Modification Treatment (ABMT) for Anxiety Disorders in Youth Who do Not Respond to CBT

Role: collaborator

NCT00162461Not ApplicableUnknown

Evaluation of CYP2C9 Activity

Role: collaborator

NCT00162435Not ApplicableUnknown

Genetic Determinants of Warfarin Anticoagulation Effect

Role: collaborator

All 4 trials loaded